Amanta Healthcare is set to launch its initial public offering (IPO) on September 1, 2025. The book-building issue comprises 1 crore fresh equity shares. The subscription window will remain open until September 3, with allotment scheduled for September 4 and a tentative listing date of September 8 on both BSE and NSE.
Price Band & Lot Size
The company is yet to announce the price band and lot size for investors. Details will be released closer to the opening date.
Issue Structure
- 50% of the net issue reserved for Qualified Institutional Buyers (QIBs)
- 35% for Retail Investors
- 15% for Non-Institutional Investors (NIIs)
Company Overview
Founded in 1994, Amanta Healthcare develops, manufactures, and markets sterile liquid formulations and medical devices. Its portfolio spans IV fluids, diluents, ophthalmic solutions, respiratory care products, irrigation solutions, and eye lubricants. The company uses Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies for advanced packaging. Amanta distributes over 45 generic products through 320 distributors in India and exports to 21 countries across Africa, Latin America, the UK, and other regions.
Financials
- FY25 revenue: ₹276.09 crore (vs. ₹281.61 crore in FY24)
- FY25 PAT: ₹10.5 crore, up 189% from ₹3.63 crore in FY24
IPO Objectives
The funds raised will primarily be used for capital expenditure, including:
- ₹70 crore for a new SteriPort manufacturing line at Hariyala
- ₹30.13 crore for a new SVP line at the same facility
- Remaining proceeds for general corporate purposes
Key Managers
- Book-running lead manager: Beeline Capital Advisors
- Registrar: MUFG Intime India
Disclaimer: This article is for informational purposes only and not investment advice.